Manucharyan; Karen

Patent Applications and Registrations

Patent applications and USPTO patent grants for Manucharyan; Karen.The latest application filed is for "methods of generating vaccines against novel coronavirus, named sars-cov-2 comprising variable epitope libraries (vels) as immunogens".

Company Profile

4.7.11

Manucharyan; Karen - Jardines En La Montana MX
Manucharyan; Karen - Mexico City MX
Manucharyan; Karen - Ciudad de Mexico MX
Manucharyan; Karen - Coyoacan N/A MX
Manucharyan; Karen - Mexico MX
Manucharyan; Karen - Los Reyes Coyoacan MX

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
METHODS OF GENERATING VACCINES AGAINST NOVEL CORONAVIRUS, NAMED SARS-COV-2 COMPRISING VARIABLE EPITOPE LIBRARIES (VELs) AS IMMUNOGENS App 20210338806 - Manucharyan; Karen	2021-11-04
Use of the GK-1 peptide as an antitumoral and/or antimetastatic agent Grant 11,020,449 - Sciutto Conde , et al. June 1, 2	2021-06-01
Use Of The Gk-1 Peptide As An Antitumoral And/or Antimetastatic Agent App 20200222495 - Sciutto Conde; Edda Lydia ; et al.	2020-07-16
Variable Epitope Library Compositions And Methods Of Therapeutic And Prophylactic Use App 20190374625 - Manucharyan; Karen ; et al.	2019-12-12
Identification And Generation Of Personalized Vaccine Components By Functional Screening Variable Epitope And Mimotope Libraries App 20190339287 - Manucharyan; Karen	2019-11-07
Variable epitope library compositions and methods of therapeutic and prophylactic use Grant 10,383,927 - Manucharyan , et al. A	2019-08-20
Use of GK-1 peptide expressed on M13 filamentous phage as pharmaceutical ingredient to enhance the efficiency of the immune response induced by vaccine or pathogen antigens Grant 9,446,122 - Sciutto Conde , et al. September 20, 2	2016-09-20
Variable Epitope Library Compositions And Methods Of Therapeutic And Prophylactic Use App 20160199471 - Manucharyan; Karen ; et al.	2016-07-14
Use Of Gk-1 Peptide Expressed On M13 Filamentous Phage As Pharmaceutical Ingredient To Enhance The Efficiency Of The Immune Response Induced By Vaccine Or Pathogen Antigens App 20140302085 - Sciutto Conde; Edda Lydia ; et al.	2014-10-09
Compositions and methods for alzheimer's disease Grant 8,394,380 - Manucharyan , et al. March 12, 2	2013-03-12
Compositions And Methods For Alzheimer's Disease App 20110065654 - Manucharyan; Karen ; et al.	2011-03-17
Compositions and methods for Alzheimer's disease Grant 7,846,892 - Manucharyan , et al. December 7, 2	2010-12-07
Immunogens for Vaccines Against Antigenically Variable Pathogens and Diseases App 20090214591 - Manucharyan; Karen ; et al.	2009-08-27
Compositions And Methods For Alzheimer's Disease App 20090023627 - Manucharyan; Karen ; et al.	2009-01-22
Compositions and methods for Alzheimer's disease App 20060024667 - Manucharyan; Karen ; et al.	2006-02-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.